Cost-effectiveness analyses and cost analyses in castration-resistant prostate cancer: A systematic review.

ABSTRACT:

Background

Treatment of metastatic prostate cancer is associated with high personal and economic burden. Recently, new treatment options for castration-resistant prostate cancer became available with promising survival advantages. However, cost-effectiveness of those new treatment options is sometimes ambiguous or given only under certain circumstances. The aim of this study was to systematically review studies on the cost-effectiveness of treatments and costs of castration-resistant prostate cancer (CRPC) and metastasizing castration-resistant prostate cancer (mCRPC) on their methodological quality and the risk of bias.

Methods

A systematic literature search was performed in the databases PubMed, CINAHL Complete, the Cochrane Library and Web of Science Core Collection for c

SUBMITTER: Grochtdreis T 

PROVIDER: S-EPMC6281264 | biostudies-literature | 2018

REPOSITORIES: biostudies-literature